Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Soligenix completes direct public offering

Soligenix Inc. (OTCBB:SNGX), Princeton, N.J.
Business: Transplant, Gastrointestinal,

Read the full 86 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE